FDA approves 'game-changing' pancreatic cancer drug

The FDA has approved a new drug called Daraxonrasib for pancreatic cancer, marking a significant advancement in treatment options for this aggressive disease in the United States.

This Wire brief sits within Fusion42's coverage of Biotech, and 20 sources have reported it.